Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “No Prior Chemotherapy”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Study completedNCT00002324
What this trial is testing

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

Who this might be right for
HIV Infections
Boehringer Ingelheim 250
Testing effectiveness (Phase 2)Study completedNCT00794235
What this trial is testing

Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine

Who this might be right for
Melanoma Stage III or IVNo Prior Chemotherapy
University of Zurich 12
Large-scale testing (Phase 3)UnknownNCT00003034
What this trial is testing

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Who this might be right for
Malignant Mesothelioma
Alfacell 300
Early research (Phase 1)Ended earlyNCT00177853
What this trial is testing

Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Pittsburgh 23
Testing effectiveness (Phase 2)Study completedNCT02077569
What this trial is testing

AKT Inhibitor in Oestrogen Positive Breast Cancer

Who this might be right for
Invasive Breast Cancer
University of Nottingham 48
Testing effectiveness (Phase 2)UnknownNCT05097248
What this trial is testing

Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Who this might be right for
Breast Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 52
Large-scale testing (Phase 3)Ended earlyNCT04729387
What this trial is testing

Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

Who this might be right for
Ovarian Cancer
Novartis Pharmaceuticals 358
Early research (Phase 1)Study completedNCT01594918
What this trial is testing

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Rahul Aggarwal 25
Testing effectiveness (Phase 2)Study completedNCT00002184
What this trial is testing

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Who this might be right for
HIV Infections
Gilead Sciences 120
Testing effectiveness (Phase 2)Study completedNCT00690560
What this trial is testing

Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Centre Antoine Lacassagne 30
Testing effectiveness (Phase 2)UnknownNCT02052128
What this trial is testing

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Who this might be right for
Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy
Arno Therapeutics 60
Testing effectiveness (Phase 2)Ended earlyNCT04871529
What this trial is testing

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Who this might be right for
Bladder Carcinoma Infiltrating the Muscle of the Bladder WallInfiltrating Renal Pelvis and Ureter Urothelial CarcinomaStage II Bladder Cancer AJCC v8
SWOG Cancer Research Network 6
Not applicableStudy completedNCT01403675
What this trial is testing

Human Ovarian Autotransplantation

Who this might be right for
Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
Samuel Kim, MD 1
Large-scale testing (Phase 3)Active Not RecruitingNCT05555732
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Daiichi Sankyo 1,170
Early research (Phase 1)Study completedNCT01220154
What this trial is testing

Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
David O'Malley 9
Testing effectiveness (Phase 2)UnknownNCT00082472
What this trial is testing

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Who this might be right for
NSCLC
Zivena 30
Not applicableStudy completedNCT00502463
What this trial is testing

Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial

Who this might be right for
Head and Neck Cancer
Austrian South Oncology Group 51
Testing effectiveness (Phase 2)Ended earlyNCT00320320
What this trial is testing

Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsMetastases
Gachon University Gil Medical Center 72
Not applicableStudy completedNCT01625702
What this trial is testing

Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University 138
Testing effectiveness (Phase 2)WithdrawnNCT01288092
What this trial is testing

BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals
Next Page